alpha-aminopyridine has been researched along with h 89 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, C; Dubé, D; Friesen, RW; Huang, Z; Kwok, E; Laliberté, F; Liu, S; Tota, MR; Veilleux, A; Young, A; Zhang, L | 1 |
| Gomes, KS; Miguel, TT; Nunes-de-Souza, RL | 1 |
| Bertagna, NB; Cruz, FC; Dos Santos, PGC; Fernandes, GJD; Miguel, TT; Queiroz, RM | 1 |
| Ashour, NH; El Sayed, NS; El-Tanbouly, DM; Khattab, MM | 1 |
4 other study(ies) available for alpha-aminopyridine and h 89
| Article | Year |
|---|---|
Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Benzamides; Biotransformation; Blotting, Western; Cell Line; Chlorides; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Enzyme Activation; Humans; Iodine Radioisotopes; Isoquinolines; Phosphodiesterase Inhibitors; Sulfonamides | 2005 |
Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Corticotropin-Releasing Hormone; Cyclic AMP-Dependent Protein Kinases; Isoquinolines; Male; Mice; Microinjections; Prefrontal Cortex; Protein Kinase Inhibitors; Receptors, Corticotropin-Releasing Hormone; Sulfonamides | 2014 |
Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway.
Topics: Aminopyridines; Animals; Anxiety; Behavior, Animal; Cobalt; Cyclic AMP-Dependent Protein Kinases; Hippocampus; Isoquinolines; Male; Maze Learning; Mice; Microinjections; Motor Activity; Protein Kinase Inhibitors; Receptors, Corticotropin-Releasing Hormone; Signal Transduction; Sulfonamides | 2021 |
Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89.
Topics: Alzheimer Disease; Aminopyridines; Amyloid beta-Peptides; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cognitive Dysfunction; Cyclopropanes; Disease Models, Animal; Hippocampus; Isoquinolines; Male; Mice; Nitric Oxide; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Streptozocin; Sulfonamides; Tauopathies | 2021 |